Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients
Introduction: Many patients coinfected with the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are using highly active antiretroviral therapy (HAART) and HCV therapy with peginterferon (PEG-IFN) and ribavirina (RBV) because the use of direct-acting antivirals is not a reality in some...
Saved in:
| Main Authors: | Luciana Brosina de Leon, Cristiane Valle Tovo, Dimas Alexandre Kliemann, Angelo Alves de Mattos, Alberi Adolfo Feltrin, Liliane Souto Pacheco, Paulo Roberto Lerias de Almeida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2016-08-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/7542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HAART and liver: is it safe?
by: Vicente Sperb Antonello, et al.
Published: (2014-11-01) -
Level of Cardiovascular Disease Risk and Associated Factors among Clients on Highly Active Antiretroviral Therapy in Vihiga County, Kenya
by: Lilian Amugitsi, et al.
Published: (2024-09-01) -
Anemia and associated factors among
HIV/AIDS patients treated with antiretroviral therapy at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia
by: Tadesse Adula Duguma, et al.
Published: (2024-09-01) -
Risk of viral failure after simplification therapy without using integrase inhibitors compared with maintenance of triple antiretroviral therapy: A systematic review and meta-analysis
by: Mateus Swarovsky Helfer, et al.
Published: (2024-11-01) -
Association between social support and viral load in adults on highly active antiretroviral therapy – Witbank, South Africa
by: Temnewo M. Habte, et al.
Published: (2020-12-01)